Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

Share Price is delayed by 15 minutes
Get Live Data
56.50    0.00 (0.00%)
Bid:
53.00
Ask:
60.00
Spread: 7.00 (13.208%)
Market Cap: £8.52m
TRT Live PriceLast checked at - London Stock Exchange

Intraday Transense Share Chart

AGM Statement

16 Nov 2015 07:00

RNS Number : 7588F
Transense Technologies PLC
16 November 2015
 

 

Transense Technologies plc

("Transense" or the "Company")

 

AGM Statement

 

 

At the Company's Annual General Meeting ("AGM") being held at 2p.m. today at finnCap's offices, 60 New Broad Street, London, EC2M 1JJ, the Chairman, David Ford, will make the following statement:

 

"As discussed in the Company's preliminary results in September, the financial year ending June 2015 had been a challenging one for the Company, in particular due to the sharp downturn in demand for commodities and consequent contraction in capital expenditure in the mining sector.

 

These restrictions have continued into the new financial year, however with our repositioning of the sales proposition of iTrack, we continue to see improvements to our sales pipeline which should enable the Translogik business to gain commercial traction.

 

The sale of IntelliSAW, as announced on 21 October 2015 to Emerson was a key milestone for the Company. The deal saw Transense receive a one-off license fee as part of the transaction to secure exclusive use of Transense Technologies' IP relating to the IntelliSAW business.

 

The strong cash position achieved by the Company, as a result of the £2.5 million placing in July and the £2.9 million we have received from the sale of IntelliSAW, will see us invest in the commercial development of the remaining divisions of the Group - Translogik and SAWSense. Specifically, we will be growing the sales and marketing teams of Translogik to drive revenue.

 

While we invest in the sales and marketing teams, we also continue to invest in R&D across the business.

 

After a challenging period for the Company we are pleased with the progress made in recent months. We are well capitalised to take full advantage of the opportunities we are seeing in all areas of the business."

 

After the formal business of the AGM a short presentation will be given to attendees and this will be available on the Company's website, http://www.transense.co.uk, from 2pm today.

 

For further information, please contact:

 

Transense Technologies plc

Graham Storey, Chief Executive

 

Tel: +44 1869 238 380

finnCap

Ed Frisby, Giles Rolls (Corporate Finance)

Tony Quirke, Alice Lane (Corporate Broking)

 

Tel: +44 20 7220 0500

IFC Advisory

Tim Metcalfe, Graham Herring, Heather Armstrong

Tel: +44 20 3053 8671

 

About Transense Technologies

 

 

Based in Oxfordshire, UK, Transense has developed patent-protected sensor systems and supporting technology for use in a variety of diverse high growth markets. Transense's Surface Acoustic Wave (SAW) wireless, battery-less, sensor systems offer significant advantages over legacy wireless sensor systems. Transense is targeting the global transport and mining industries, and the global torque, temperature and pressure sensing markets, via its two trading divisions,Translogik and SAWSense.

 

Transense's shares are admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: "TRT").

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMUVRRRVUAAAUA
Date   Source Headline
5th Feb 20146:20 pmRNSExercise of Warrants
5th Feb 20147:00 amRNSAward of Options
4th Feb 20147:00 amRNSInterim Results
7th Nov 20136:28 pmRNSExercise of Warrants
29th Oct 20133:25 pmRNSHolding(s) in Company
11th Oct 20134:05 pmRNSResult of AGM
11th Oct 20137:00 amRNSAGM Statement and Directorate Change
7th Oct 201312:06 pmRNSHolding(s) in Company
20th Sep 20139:54 amRNSDirector/PDMR Shareholding
19th Sep 20139:41 amRNSExercise of Warrants
17th Sep 20133:54 pmRNSPosting of Accounts and Notice of AGM
16th Sep 20137:00 amRNSFinal Results
3rd Sep 20134:20 pmRNSHolding(s) in Company
27th Aug 20137:00 amRNSMajor iTrack Order from Otraco in Chile
20th Aug 20135:52 pmRNSExercise of Warrants and Exercise of Options
1st Aug 20135:40 pmRNSExercise of Warrants
1st Aug 20137:00 amRNSTrading Update and Notice of Results
30th Jul 20135:30 pmRNSIssue of Equity
11th Jul 20134:46 pmRNSOffer, Further Placing and Exercise of Options
8th Jul 201312:14 pmRNSHolding(s) in Company
2nd Jul 201312:27 pmRNSResult of General Meeting
2nd Jul 20137:00 amRNSGeneral Meeting Statement
13th Jun 20132:45 pmRNSHolding(s) in Company
12th Jun 20132:10 pmRNSHolding(s) in Company
10th Jun 20137:00 amRNSCompletion of First Placing & Exercise of Warrants
7th Jun 20137:01 amRNSPlacing and Offer for Subscription
7th Jun 20137:00 amRNSMajor iTrack Contract with Anglo American
28th May 201310:26 amRNSIntelliSAW order from partner ETT worth US$450,000
28th May 20137:00 amRNSTranslogik Probe Order From Dunlop Japan
13th May 20137:00 amRNSTranslogik two largest probe orders
10th May 20136:10 pmRNSExercise of Warrants
17th Apr 20134:00 pmRNSExercise of Warrants
15th Apr 201310:40 amRNSHolding(s) in Company
28th Mar 201312:21 pmRNSIssue of Equity
28th Mar 201312:20 pmRNSInterim Results
5th Mar 20137:00 amRNSIntelliSAW Update
15th Feb 20133:00 pmRNSExercise of Warrants
7th Feb 201311:00 amRNSExercise of Warrants
16th Jan 20134:05 pmRNSExercise of Warrants
30th Nov 20124:05 pmRNSTotal Voting Rights
27th Nov 20125:30 pmRNSExercise of Warrants
20th Nov 20123:05 pmRNSExercise of Warrants
8th Nov 20127:00 amRNSAppointment as Sole Broker
29th Oct 20125:00 pmRNSResult of AGM
29th Oct 20124:10 pmRNSReplacement: Change of Name of Nominated Adviser
29th Oct 20127:00 amRNSChange of name of Nominated Adviser & Joint Broker
26th Oct 20127:00 amRNSChange of Name of Nominated Adviser
26th Oct 20127:00 amRNSAGM Statement
3rd Oct 20127:00 amRNSFinal Results and Notice of AGM
17th Sep 20127:00 amRNSExercise of Warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.